Historical record - last NADAC effective date: 12/21/2022
Product Information
MONTELUKAST SOD 4 MG TAB CHEW is a generic product labeled by Lannett Company Inc., priced at $0.0862 per EA under NDC 62175020446. Its NADAC has been published 476 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Lannett Company Inc.NDC
62175020446
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
MONTELUKAST SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA200405FDA Approved
8/3/2012
TE Code
AB
On Market Since
8/3/2012
Pharmacological Classes
Price Statistics
The NADAC for MONTELUKAST SOD 4 MG TAB CHEW has been published 476 times since Nov 28, 2013, and over the history we have for it it has declined 75.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0862 per EA |
|---|---|
| All-time high | $0.3779 (Feb 12, 2014) |
| All-time low | $0.0862 (Dec 21, 2022) |
| Median price | $0.1466 |
| Average price | $0.1872 |
| Largest weekly change | +20.6% (Aug 21, 2019) |
| Weeks tracked | 476 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-17.4%
All
-75.3%
Last surveyed Jan 4, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Montelukast Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MONTELUKAST SOD 4 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 4 MG TAB CHEW, manufactured by Lannett Company Inc., is $0.0862 per EA (NDC 62175020446), effective Jan 4, 2023.
How has the price of MONTELUKAST SOD 4 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for MONTELUKAST SOD 4 MG TAB CHEW has declined 75.3%. It has been tracked across 476 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 4 MG TAB CHEW?
Since Nov 28, 2013, the NADAC for MONTELUKAST SOD 4 MG TAB CHEW has ranged from a low of $0.0862 (Dec 21, 2022) to a high of $0.3779 (Feb 12, 2014), with a median of $0.1466 per EA.
Are there cheaper alternatives to MONTELUKAST SOD 4 MG TAB CHEW?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MONTELUKAST SOD 4 MG TAB CHEW, is $0.0753 per EA — about 13% below MONTELUKAST SOD 4 MG TAB CHEW.
Who manufactures MONTELUKAST SOD 4 MG TAB CHEW?
MONTELUKAST SOD 4 MG TAB CHEW (NDC 62175020446) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.